Conditional survival of patients with diffuse large B-cell lymphoma

Cancer

Volumn 106, Issue 10, 2006, Pages 2165-2170

  Moller, Michael B ^a,b   Pedersen, Niels T ^a,b   Christensen, Bjarne E ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Conditional survival; Diffuse large B cell lymphoma; Lymphoma; Outcome; Prognosis

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; DENMARK; HUMAN; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DENMARK; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33646366927     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21877     Document Type: Article

References (16)

1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J Clin Oncol. 1998;16:2780-2795.
2. Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987-994.
3. Henson DE, Ries LA, Carriaga MT. Conditional survival of 56,268 patients with breast cancer. Cancer. 1995;76:237-242.
4. Merrill RM, Henson DE, Ries LAG. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998;41:1097-1106.
5. Kato I, Severson RK, Schwartz AG. Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data. Cancer. 2001;92:2211-2219.
6. Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer. 1999;85:485-491.
7. Merrill RM, Henson DE, Barnes M. Conditional survival among patients with carcinoma of the lung. Chest. 1999;116:697-703.
8. Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol. 2003;21:3035-3040.
9. Henson DE, Ries LA. On the estimation of survival. Semin Surg Oncol. 1994;10:2-6.
10. Mounier N, Morel P, Haioun C, et al. A multivariate analysis of the survival of patients with aggressive lymphoma. Variations in the predictive value of prognostic factors during the course of the disease. Cancer. 1998;82:1952-1962.
11. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
12. Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation-a population-based study of 1575 cases. Br J Haematol. 2004;124:151-159.
13. StatBank Denmark. Available from URL: http://www.statbank.dk [accessed Sept. 14, 2005].
14. Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol. 2005;23:5027-5033.
15. Hequet O, Le QH, Moullet I, et al. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol. 2004;22:1864-1871.
16. Arriagada R, Rutqvist LE, Le MG. Postmastectomy radiotherapy: randomized trials. Semin Radiat Oncol. 1999;9:275-286.